Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Pheast Therapeutics
Servier
Actuate Therapeutics Inc.
Bristol-Myers Squibb
Hoosier Cancer Research Network
St. Jude Children's Research Hospital
Incyte Corporation
University of Colorado, Denver
St. Jude Children's Research Hospital
Emory University
St. Jude Children's Research Hospital
Novo Nordisk A/S
University of Michigan Rogel Cancer Center
Leaf Vertical Inc.
Medical University of South Carolina
Dartmouth-Hitchcock Medical Center
University of Southampton
Baylor College of Medicine
Gustave Roussy, Cancer Campus, Grand Paris